C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
10/2002
10/10/2002	WO2002080150A2 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
10/10/2002	WO2002079183A1 Halogenated rhodamine derivatives and applications thereof
10/10/2002	WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002	WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002050067A3 Pharmaceutical heterocyclic compounds
10/10/2002	US20020147353 Drugs; oxidaton resistance
10/10/2002	US20020147350 Process for producing isocoumarins and intermediates for the same
10/10/2002	US20020147348 Methods of making magenta colorants for ink systems
10/10/2002	US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
10/10/2002	US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002	US20020146588 Novel compound for red organic electroluminescent elements and devices
10/10/2002	DE10117464A1 Optical data medium for information recording, has cover layer and adhesive layer having preset total thickness, and recorded and readout with focussing objective lens setup having preset numerical aperture
10/10/2002	CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002	WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002	EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002	EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002	EP1000025A4 Substituted naphthopyrans
10/09/2002	EP0944613B1 Benzopyran derivatives
10/09/2002	EP0900237B1 Photoactive compounds for use with narrow wavelength band ultraviolet (uv) curing systems
10/09/2002	CN1373225A Method for preparing intermidiate of VE
10/09/2002	CN1373129A Process for extracting oligoprotoanthocyanidin from plant
10/09/2002	CN1373128A Enzyme-removing degumming process of preparing rutin
10/09/2002	CN1092194C Diaminopyrimidines, pharmaceutical compositions contg. them and their use as antibacterial
10/09/2002	CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002	US6462203 In presence of palladium catalyst without oxygen activation
10/08/2002	US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia,
10/08/2002	US6462015 Octahyhydro-3- and 4-methyl-2h-1-benzopyran-2-ones intensifiers; low cost; synthesized from cyclohexanone or cyclopentanone by amination, alkylesterification, deamination and cyclization
10/08/2002	US6461838 Polyketides
10/08/2002	CA2081766C Leukotriene b4 antagonists
10/03/2002	WO2002077984A1 Optical data carrier containing a xanthene dye in the information layer thereof as a light-absorbing compound
10/03/2002	WO2002076970A2 Tocopherol succinate derivatives and compositions
10/03/2002	WO2002076938A2 Carboxybenzopyran derivatives and compositions
10/03/2002	WO2002076937A2 Aminobenzopyran derivatives and compositions
10/03/2002	WO2002076448A1 Molecular conjugates for use in treatment of cancer
10/03/2002	WO2002076397A2 Telomerase inhibitors and methods of their use
10/03/2002	WO2002076395A2 Agents and methods for treatment of cancer
10/03/2002	WO2002076381A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
10/03/2002	WO2002062333A8 Use of 9h-xanthenes in a method of inhibiting viral replication targeting the nucleocapsid protein
10/03/2002	WO2002062293A3 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
10/03/2002	WO2001020331A9 Substrates and screening methods for transport proteins
10/03/2002	US20020143193 Process for preparing 3-isochromanone
10/03/2002	US20020142484 Synthetic tracer for use in the detection of tetrahydrocannabinols and cannabinol
10/03/2002	US20020142083 Process for the production of tocotrienols
10/03/2002	US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002	US20020142012 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/03/2002	CA2441484A1 Molecular conjugates for use in treatment of cancer
10/03/2002	CA2441394A1 Agents and methods for treatment of cancer
10/02/2002	EP1245553A2 Palladium-catalysed synthesis of aryl ethers
10/02/2002	CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002	CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002	CA2342675A1 Halogenated rhodamine derivatives and applications thereof
10/01/2002	US6458974 Synthesis of β-lapachone and its intermediates
10/01/2002	US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002	US6458785 Aids therapy
10/01/2002	US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
09/2002
09/26/2002	WO2002074971A1 Flavonoid compound and process for producing the same
09/26/2002	WO2002074777A2 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity
09/26/2002	WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002	WO2002074307A1 Treatment of restenosis
09/26/2002	WO2002074036A2 Substituted benzopyranones as telomerase inhibitors
09/26/2002	US20020137952 Synthesis of beta-lapachone and its intermediates
09/26/2002	US20020137789 Anticancer agents
09/26/2002	US20020137693 Comprising an admixture of a natural inhibitor of epidermal growth factor receptor (EGFR) activation or a derivative or analog and a dermatological carrier; antipeeling agents; genistein and other isoflavones and other plant extracts
09/26/2002	US20020137201 Detection of transmembrane potentials by optical methods
09/26/2002	CA2440106A1 Substituted benzopyranones as telomerase inhibitors
09/25/2002	WO2001074354A1 DIURETICS CONTAINING η-TOCOTRIENOL
09/25/2002	EP1243586A1 Phloridzin-rich phenolic fraction and its use as cosmetic, food or nutritional agent
09/25/2002	EP1243583A1 Heterocyclic compounds having sulfonamide groups
09/25/2002	EP1242379A1 Curcumin analogues for treating cancer
09/25/2002	EP1242361A1 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
09/25/2002	EP1070059B1 Chromanone and thiochromanone derivatives
09/25/2002	EP0980535B1 Photochromic compositions, photochromic compounds (co)polymer matrices
09/25/2002	EP0912534B1 Muscarinic antagonists
09/25/2002	CN1371372A Novel chalcones
09/25/2002	CN1371371A Novel derivatives of flavones, xanthones and coumarins
09/25/2002	CN1371370A Chalcone coumarins
09/25/2002	CN1370776A Separating prepn process of gallo catechin and gallate
09/25/2002	CN1370766A Green extraction process of high-purity tea polyphenol
09/24/2002	US6455714 Labeled vitamin D compounds and the use thereof
09/24/2002	US6455708 Processes for the preparation of 4-substituted benzopyran derivatives
09/24/2002	US6455587 Aromatic sulfonyl derivatives
09/24/2002	US6455578 Aromatic derivatives and iron complexes thereof for the use as normalizing agents of the iron level
09/24/2002	US6455577 Flavanone derivatives and composition for preventing or treating blood lipid level-related diseases comprising same
09/24/2002	US6455520 Benzamide derivatives and their use as cytokine inhibitors
09/19/2002	WO2002073214A2 Novel reagents for detecting cannabinoids
09/19/2002	WO2002072532A1 7, 9-substituted tetracycline compounds
09/19/2002	WO2002072530A1 Permanent surface modifiers
09/19/2002	WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
09/19/2002	US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
09/19/2002	US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
09/19/2002	DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use
09/19/2002	CA2441189A1 Novel reagents for detecting cannabinoids
09/19/2002	CA2439221A1 Permanent surface modifiers
09/18/2002	EP1241167A1 3-ethyl-, 3-propyl- or 3-butyl-chroman and -thiochroman derivatives
09/18/2002	EP1241166A1 3-methyl-chroman and -thiochroman derivatives
09/18/2002	EP1241165A1 Optically active chroman and thiochroman derivatives
09/18/2002	EP1240156A1 3-methyl-chromane or thiochromane derivatives
09/18/2002	EP1240155A1 Metal salts of 3-methyl-chromane or thiochromane derivatives

1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 242